Mounjaro side effects

Mounjaro is potent antidiabetic medication. However, patients can sometimes experience side effects that are not to be neglected.

Mounjaro side effects
Viktor Simunović, Viktor Simunović
19 Mar 2024.

Mounjaro, a potent therapeutic agent, has been reported to cause side effects, the severity of which can range from mild to severe. It's encouraged to note that the correlation between these conditions and Mounjaro necessitates further investigation. Pursuing this path can equip individuals with greater insight into the profile of this complex therapeutic.

Thyroid cancer

Associated with the use of Mounjaro, an alarming increase in the incidence of thyroid cancer has been documented, underscoring the need for vigilant monitoring and further scientific investigation.

Recent data suggests that Mounjaro may cause a proliferation of malignant thyroid tumors, potentially linked to its disruptive effects on the endocrine system. The symptoms of thyroid cancer, which include a lump in the neck, difficulty swallowing, and vocal changes, are often subtle, making early detection vital.

Further research is needed to determine the causality and explore possible preventive measures. Overall, these findings highlight the importance of considering potential health risks when using substances such as Mounjaro.

Gallbladder problems

Mounjaro's impact on gallbladder health signifies another area of concern, as an increasing number of patients report gallbladder-related complications following its use. These complications include gallstones and cholecystitis, or inflammation of the gallbladder.

Scientific analysis has shown that Mounjaro can cause these issues by altering the standard bile composition, leading to the formation of gallstones. Subsequently, these stones can stimulate an inflammatory response, further exacerbating the problem.


This inflammation of the pancreas, triggered by Mounjaro usage, can lead to severe abdominal pain, nausea, and fever.

Clinical studies indicate that the risk of pancreatitis increases when using Mounjaro, especially in patients with a history of gallstones or high triglyceride levels. The pathophysiology involves the overstimulation of pancreatic acinar cells, leading to inflammation and necrosis.

Allergic reaction

Even though Mounjaro is safe for most, a small percentage may experience an allergic reaction. This could range from mild symptoms, such as rashes, itching, and hives, to a more serious allergic reaction, such as anaphylaxis.

Healthcare providers who prescribe Mounjaro must inform their patients about these potential side effects. If signs of an allergic reaction are detected, immediate medical attention is required.

Kidney injury

When patients take Mounjaro, monitoring kidney function is important, as this medication may worsen pre-existing conditions or trigger new ones. Studies have shown a correlation between Mounjaro use and kidney injury, particularly in individuals with type diabetes. The mechanism of injury is not fully understood, but it is believed that the drug's metabolic effects may play a role.

The consequences of kidney injury from Mounjaro include a range of severe side effects, from renal impairment to complete kidney failure.

Diabetic retinopathy

Mounjaro, also known as tirzepatide, is often linked to causing low blood sugar, a common side effect that can worsen diabetic retinopathy. This condition is characterized by damage to the retina's blood vessels, leading to visual impairment. The symptoms of low blood sugar, like blurred vision, may imitate the early indications of diabetic retinopathy, making the diagnosis and management more challenging. Hence, while Mounjaro can improve glycemic control to a great extent, the potential risk of hastening diabetic retinopathy progression must be carefully considered during treatment planning.


A less common but significant side effect of Mounjaro is the exacerbation of gastroparesis, which slows or stops food movement from the stomach to the small intestine. This impairment is usually caused by damage to the vagus nerve, often associated with diabetes, but it can also be linked to endocrine disorders such as hypothyroidism.

Whether Mounjaro directly triggers gastroparesis or amplifies its existing symptoms remains a subject of ongoing research. In rare cases, patients with multiple endocrine neoplasia syndrome type 2, a genetic disorder that increases the risk of developing tumors in glands like the medullary thyroid, have reported worsening gastroparesis after starting Mounjaro.


Among the frequently reported side effects of Mounjaro, nausea stands out as a widespread manifestation, often resulting in significant discomfort for patients.

The mechanism behind this symptom is the drug's impact on the gastrointestinal system, specifically the chemoreceptor trigger zone in the brain. This area, located in the medulla oblongata, detects toxins in the blood and cerebrospinal fluid and communicates this information to the vomiting center, thereby inducing nausea. Mounjaro, by interacting with the neurotransmitters in this zone, can trigger a false alarm, leading to the sensation of nausea.

The severity of this side effect varies among patients and may be influenced by factors such as dosage, patient's age, and individual physiological responses.


This side effect will likely result from the drug's interaction with the gastrointestinal tract. Specifically, Mounjaro's active ingredient may disrupt the balance of gut flora, leading to a rapid increase in bowel movements.

Although generally mild to moderate, the diarrheal episodes can lead to dehydration and electrolyte imbalance if not managed correctly. In clinical trials, the percentage of patients experiencing diarrhea was markedly higher in the Mounjaro-treated group than in the placebo group.


Surprisingly, constipation is another gastrointestinal side effect reported by some patients taking Mounjaro, seemingly contradicting the aforementioned diarrheal effects.

While the exact mechanism of this paradoxical effect is not fully understood, it may be related to the drug's interaction with the body's serotonin receptors, which play an essential role in regulating bowel movements. Some theories suggest that Mounjaro may cause a temporary imbalance in the gut's serotonin levels, leading to variations in bowel habits. In some cases, this might slow down the transit of food and waste, leading to constipation. Individual genetic factors and diet could influence these disparate effects.

How do you manage side effects?

To begin, healthcare professionals must provide patients with detailed education about the possible side effects. This guarantees they can identify the symptoms early and promptly seek medical assistance.

Secondly, regular monitoring of the patient's health status is vital. This allows for early detection of any adverse effects and timely intervention.

Lastly, symptomatic treatment can be used to manage some side effects. For instance, if a patient experiences nausea, antiemetics could be prescribed. However, any treatment regimen must respect the patient's tolerance and response to Mounjaro. Adjustments to the dosage or schedule may be necessary, always under the close supervision of a healthcare provider.

How long do Mounjaro's side effects last?

The longevity of Mounjaro's side effects depends on several factors, including the individual's overall health, the dosage administered, and the body's metabolic rate. Generally, side effects may diminish within a few weeks after the commencement of the treatment. However, in some cases, they might last for several months or even longer.

Persistent side effects may indicate that the body is not adapting well to the medication, necessitating a review of the treatment plan. Monitoring the duration and severity of side effects is vital, as this information can guide healthcare professionals in tailoring the most effective and tolerable treatment regimen.



While consuming Mounjaro, it is important to exercise caution with alcohol, as it may intensify specific side effects and pose potential health risks.

Alcohol can interact negatively with Mounjaro, potentially exacerbating dizziness, drowsiness, and impairment in thinking or judgment, hence affecting the individual's motor coordination and decision-making skills. It may also increase the risk of gastrointestinal complications like stomach bleeding, particularly in individuals with a history of gastric ulcers.

Liver function may also be adversely affected, given that both Mounjaro and alcohol are metabolized in the liver, and their concurrent use could lead to an overload, causing hepatotoxicity. As a result, it is advisable to limit alcohol intake during Mounjaro therapy or abstain completely to guarantee therapeutic benefits and minimize the risk of adverse effects.

Pregnancy and breastfeeding

Special precautions must be taken when contemplating Mounjaro therapy during pregnancy and breastfeeding due to potential risks to the mother and child.

The mechanisms of Mounjaro can alter hormonal balances, which may have implications for fetal development and lactation. Although clinical trials on pregnant and lactating populations are limited, it is essential to ponder the pharmacokinetics and pharmacodynamics of Mounjaro. The drug could potentially cross the placental barrier, thereby exposing the fetus to the drug. Similarly, the drug could be excreted into breast milk, posing potential risks to a nursing infant.

Reporting side effects

Should any adverse reactions to Mounjaro occur, it is essential to promptly report these side effects to your healthcare provider for thorough evaluation and management. Timely reporting facilitates early detection of potential drug-related problems and aids in the identification of rare, serious side effects that may not have been previously documented.

This reporting can be instrumental in ensuring that patients receive the most appropriate care and that physicians can make well-informed decisions about continued therapy. It also contributes to the broader pharmacovigilance effort, helping to build a more detailed understanding of a drug's safety profile. Documenting the onset, duration, and severity of symptoms and any concurrent medications or health conditions can be particularly helpful in this process.

When to see a doctor?

Mild symptoms such as fatigue and nausea may not necessitate immediate medical attention. However, if these symptoms persist or intensify, it is advisable to seek medical advice.

More alarming side effects include severe dizziness, irregular heartbeat, or signs of kidney problems, such as a change in the amount of urine. If experiencing severe side effects, it is imperative to consult a healthcare professional without delay to minimize potential harm and ensure favorable treatment outcomes.

We love to share our knowledge

Related news

EUDoctor Logo
© 2024 EUDoctor, All rights reserved
Developed by